Boston Scientific To Acquire Axonics For About $3.7 Bln

Medical technology company Boston Scientific has announced its plan to acquire Axonics, a company specializing in medical devices, for a cash deal worth $3.7 billion. The acquisition was agreed upon at a price of $71 per share, giving Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion. The deal is expected to benefit both companies and further strengthen Boston Scientific’s presence in the medical device market.